ArticleBMC cancer2023

Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma-an exploration of surrogate endpoint.

Zewei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.